SereNeuro Therapeutics
- Biotech or pharma, therapeutic R&D
SereNeuro Therapeutics is developing non-opioid, first-in-class, DMOAD SN101 iPS cell therapy for chronic knee osteoarthritis pain and sequelae.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}